Fortitude Family Office »

Avalo Therapeutics Ord shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $940 63 14.94

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Avalo Therapeutics Ord

FMR
Caligan Partners
BVF
venBio Select Advisor
Affinity Asset Advisors
Logos Global Management
Nantahala Capital Management
UBS Group
Caption Management
Point72 Asset Management
Farallon Capital Management
Rtw Investments
Adage Capital Partners GP
Millennium Management
Vanguard Group

View all funds holding Avalo Therapeutics Ord